Effects of anaesthetics on the loss of nigrostriatal dopaminergic neurons by 6-hydroxydopamine in rats

Summary.Various studies use ketamine/xylazine, fentanyl/medetomidine, etorphine/methotrimeprazine, and isoflurane anaesthesia for creating the 6-hydroxydopamine (6-OHDA)-lesion rat model of Parkinson’s disease. As these anaesthetics are known to modulate uptake and turnover of dopamine and that 6-OHDA-induced neurotoxicity is also dependents on uptake/turnover, we studied the effects of these anaesthetics on the extent of nigrostriatal dopaminergic damage caused by 6-OHDA. Infusion of 8 µg of 6-OHDA into the medial forebrain bundle significantly reduced the numbers of dopaminergic cells in nigra and striatal concentrations of dopamine in animals anaesthetized with fentanyl/medetomidine, etorphine/methotrimeprazine and isoflurane but not with ketamine/xylazine. In the latter group, however, increasing the dose of 6-OHDA to 10 and 12 µg resulted in a moderate (15 and 29%), but significant loss of dopaminergic cells. A severe loss of dopaminergic cells (59% and 81%) was seen with these doses in isoflurane-anaesthetized animals, but with only 8 µg in etorphine/methotrimeprazine-anaesthetized animals. Thus, these results suggest that the extent of nigrostriatal dopaminergic neuronal loss with 6-OHDA seems to be influenced by anaesthetic used during the surgery.

[1]  D. Lorrain,et al.  Effects of ketamine and n-methyl-d-aspartate on glutamate and dopamine release in the rat prefrontal cortex: modulation by a group II selective metabotropic glutamate receptor agonist LY379268 , 2003, Neuroscience.

[2]  D. Dexter,et al.  Chronic L‐DOPA administration is not toxic to the remaining dopaminergic nigrostriatal neurons, but instead may promote their functional recovery, in rats with partial 6‐OHDA or FeCl3 nigrostriatal lesions , 2001, Movement disorders : official journal of the Movement Disorder Society.

[3]  H. Hemmings,et al.  General Anesthetic Actions on Norepinephrine, Dopamine, and γ-Aminobutyric Acid Transporters in Stably Transfected Cells , 2002 .

[4]  Z. Pan.  -Opposing actions of the ?-opioid receptor , 1998 .

[5]  D. Dexter,et al.  Dose- and sex-dependent effects of the neurotoxin 6-hydroxydopamine on the nigrostriatal dopaminergic pathway of adult rats: differential actions of estrogen in males and females , 2003, Neuroscience.

[6]  G. Paxinos,et al.  The Rat Brain in Stereotaxic Coordinates , 1983 .

[7]  J. Obeso,et al.  Dopamine Cell Degeneration Induced by Intraventricular Administration of 6-Hydroxydopamine in the Rat: Similarities with Cell Loss in Parkinson's Disease , 2001, Experimental Neurology.

[8]  David Blum,et al.  Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease , 2001, Progress in Neurobiology.

[9]  T. Reader,et al.  Effects of denervation and hyperinnervation on dopamine and serotonin systems in the rat neostriatum: implications for human Parkinson's disease. , 1999, Neurochemistry international.

[10]  G. Knudsen,et al.  Interference of anaesthetics with radioligand binding in neuroreceptor studies , 2003, European Journal of Nuclear Medicine and Molecular Imaging.

[11]  G. Di Chiara,et al.  Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats. , 1988, The Journal of pharmacology and experimental therapeutics.

[12]  T. Reader,et al.  Review article Effects of denervation and hyperinnervation on dopamine and serotonin systems in the rat neostriatum: implications for human Parkinsons disease , 1999, Neurochemistry International.

[13]  A. Nanji,et al.  Free radical formation during ketamine anesthesia in rats: a cautionary note. , 1998, Free Radical Biology & Medicine.

[14]  W. H. Oertel,et al.  Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: A combined retrograde tracing and immunocytochemical study in the rat , 1994, Neuroscience.

[15]  Hideo Tsukada,et al.  Isoflurane anesthesia enhances the inhibitory effects of cocaine and GBR12909 on dopamine transporter: PET studies in combination with microdialysis in the monkey brain , 1999, Brain Research.

[16]  H. Hemmings,et al.  General Anesthetic Actions on Norepinephrine, Dopamine, and &ggr;-Aminobutyric Acid Transporters in Stably Transfected Cells , 2002, Anesthesia and analgesia.

[17]  K. Sato,et al.  Ketamine stereoselectively inhibits rat dopamine transporter , 1999, Neuroscience Letters.

[18]  B. Halliwell,et al.  6‐Hydroxydopamine increases the hydroxylation and nitration of phenylalanine in vivo: implication of peroxynitrite formation , 2001, Journal of neurochemistry.

[19]  John Votaw,et al.  Interaction of Isoflurane with the Dopamine Transporter , 2003, Anesthesiology.

[20]  M. Horne,et al.  Timecourse of striatal re‐innervation following lesions of dopaminergic SNpc neurons of the rat , 2003, The European journal of neuroscience.

[21]  Daniel P. McLaughlin,et al.  Stereoselective effects of ketamine on dopamine, serotonin and noradrenaline release and uptake in rat brain slices , 2004, Neurochemistry International.

[22]  K. Tipton,et al.  Nature of Inhibition of Mitochondrial Respiratory Complex I by 6‐Hydroxydopamine , 1996, Journal of neurochemistry.

[23]  P. Flecknell,et al.  Laboratory animal anaesthesia , 1996 .

[24]  M. Youdim,et al.  Mechanism of 6-hydroxydopamine neurotoxicity. , 1997, Journal of neural transmission. Supplementum.

[25]  Fred H. Gage,et al.  Partial lesion of the substantia nigra: relation between extent of lesion and rotational behavior , 1991, Brain Research.

[26]  A. Ylinen,et al.  Atipamezole, an alpha2-adrenoceptor antagonist, augments the effects of L-DOPA on evoked dopamine release in rat striatum. , 2003, European journal of pharmacology.

[27]  N. Koshikawa,et al.  Fentanyl increases dopamine release in rat nucleus accumbens: involvement of mesolimbic mu- and delta-2-opioid receptors , 1999, Neuroscience.

[28]  Blunt,et al.  Long‐term protection of the rat nigrostriatal dopaminergic system by glial cell line‐derived neurotrophic factor against 6‐hydroxydopamine in vivo , 1998, The European journal of neuroscience.

[29]  Anders Björklund,et al.  Characterization of Behavioral and Neurodegenerative Changes Following Partial Lesions of the Nigrostriatal Dopamine System Induced by Intrastriatal 6-Hydroxydopamine in the Rat , 1998, Experimental Neurology.